The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Voriconazole-Global Market Insights and Sales Trends 2025
Synopsis
The global Voriconazole market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Voriconazole in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Voriconazole market. Injection Voriconazole, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Voriconazole Freeze-dried Powder segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Voriconazole market, driven by demand from China, the second largest economy with some signs of stabilising, the Voriconazole market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Voriconazole, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Voriconazole market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Voriconazole market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Voriconazole sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Voriconazole covered in this report include Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, Squibb, Sandoz, Daiichi Sankyo and GSK, etc.
The global Voriconazole market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Teva
GeneTech Pharm
Novartis
Mylan
Squibb
Sandoz
Daiichi Sankyo
GSK
Cilag AG
Macherey-Nagel GmbH
Abbott
Takeda
Sichuan Beauty Sport Huakang Pharmaceutical
Jincheng HEALTH Pharmaceutical
Ebang Pharmaceutical
Aditya Pharma
Taj Pharmaceuticals
Global Voriconazole market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Voriconazole market, Segment by Type:
Injection Voriconazole
Voriconazole Freeze-dried Powder
Global Voriconazole market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Voriconazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Voriconazole market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Voriconazole in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Voriconazole market. Injection Voriconazole, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Voriconazole Freeze-dried Powder segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Voriconazole market, driven by demand from China, the second largest economy with some signs of stabilising, the Voriconazole market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Voriconazole, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Voriconazole market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Voriconazole market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Voriconazole sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Voriconazole covered in this report include Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, Squibb, Sandoz, Daiichi Sankyo and GSK, etc.
The global Voriconazole market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Teva
GeneTech Pharm
Novartis
Mylan
Squibb
Sandoz
Daiichi Sankyo
GSK
Cilag AG
Macherey-Nagel GmbH
Abbott
Takeda
Sichuan Beauty Sport Huakang Pharmaceutical
Jincheng HEALTH Pharmaceutical
Ebang Pharmaceutical
Aditya Pharma
Taj Pharmaceuticals
Global Voriconazole market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Voriconazole market, Segment by Type:
Injection Voriconazole
Voriconazole Freeze-dried Powder
Global Voriconazole market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Voriconazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Voriconazole Market Overview
1.1 Voriconazole Product Overview
1.2 Voriconazole Market Segment by Type
1.2.1 Injection Voriconazole
1.2.2 Voriconazole Freeze-dried Powder
1.3 Global Voriconazole Market Size by Type
1.3.1 Global Voriconazole Market Size Overview by Type (2018-2029)
1.3.2 Global Voriconazole Historic Market Size Review by Type (2018-2023)
1.3.3 Global Voriconazole Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Voriconazole Sales Breakdown by Type (2018-2023)
1.4.2 Europe Voriconazole Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Voriconazole Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Voriconazole Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Voriconazole Sales Breakdown by Type (2018-2023)
2 Global Voriconazole Market Competition by Company
2.1 Global Top Players by Voriconazole Sales (2018-2023)
2.2 Global Top Players by Voriconazole Revenue (2018-2023)
2.3 Global Top Players by Voriconazole Price (2018-2023)
2.4 Global Top Manufacturers Voriconazole Manufacturing Base Distribution, Sales Area, Product Type
2.5 Voriconazole Market Competitive Situation and Trends
2.5.1 Voriconazole Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Voriconazole Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Voriconazole as of 2022)
2.7 Date of Key Manufacturers Enter into Voriconazole Market
2.8 Key Manufacturers Voriconazole Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Voriconazole Status and Outlook by Region
3.1 Global Voriconazole Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Voriconazole Historic Market Size by Region
3.2.1 Global Voriconazole Sales in Volume by Region (2018-2023)
3.2.2 Global Voriconazole Sales in Value by Region (2018-2023)
3.2.3 Global Voriconazole Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Voriconazole Forecasted Market Size by Region
3.3.1 Global Voriconazole Sales in Volume by Region (2024-2029)
3.3.2 Global Voriconazole Sales in Value by Region (2024-2029)
3.3.3 Global Voriconazole Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Voriconazole by Application
4.1 Voriconazole Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Voriconazole Market Size by Application
4.2.1 Global Voriconazole Market Size Overview by Application (2018-2029)
4.2.2 Global Voriconazole Historic Market Size Review by Application (2018-2023)
4.2.3 Global Voriconazole Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Voriconazole Sales Breakdown by Application (2018-2023)
4.3.2 Europe Voriconazole Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Voriconazole Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Voriconazole Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Voriconazole Sales Breakdown by Application (2018-2023)
5 North America Voriconazole by Country
5.1 North America Voriconazole Historic Market Size by Country
5.1.1 North America Voriconazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Voriconazole Sales in Volume by Country (2018-2023)
5.1.3 North America Voriconazole Sales in Value by Country (2018-2023)
5.2 North America Voriconazole Forecasted Market Size by Country
5.2.1 North America Voriconazole Sales in Volume by Country (2024-2029)
5.2.2 North America Voriconazole Sales in Value by Country (2024-2029)
6 Europe Voriconazole by Country
6.1 Europe Voriconazole Historic Market Size by Country
6.1.1 Europe Voriconazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Voriconazole Sales in Volume by Country (2018-2023)
6.1.3 Europe Voriconazole Sales in Value by Country (2018-2023)
6.2 Europe Voriconazole Forecasted Market Size by Country
6.2.1 Europe Voriconazole Sales in Volume by Country (2024-2029)
6.2.2 Europe Voriconazole Sales in Value by Country (2024-2029)
7 Asia-Pacific Voriconazole by Region
7.1 Asia-Pacific Voriconazole Historic Market Size by Region
7.1.1 Asia-Pacific Voriconazole Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Voriconazole Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Voriconazole Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Voriconazole Forecasted Market Size by Region
7.2.1 Asia-Pacific Voriconazole Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Voriconazole Sales in Value by Region (2024-2029)
8 Latin America Voriconazole by Country
8.1 Latin America Voriconazole Historic Market Size by Country
8.1.1 Latin America Voriconazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Voriconazole Sales in Volume by Country (2018-2023)
8.1.3 Latin America Voriconazole Sales in Value by Country (2018-2023)
8.2 Latin America Voriconazole Forecasted Market Size by Country
8.2.1 Latin America Voriconazole Sales in Volume by Country (2024-2029)
8.2.2 Latin America Voriconazole Sales in Value by Country (2024-2029)
9 Middle East and Africa Voriconazole by Country
9.1 Middle East and Africa Voriconazole Historic Market Size by Country
9.1.1 Middle East and Africa Voriconazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Voriconazole Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Voriconazole Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Voriconazole Forecasted Market Size by Country
9.2.1 Middle East and Africa Voriconazole Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Voriconazole Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Voriconazole Products Offered
10.1.5 Pfizer Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Voriconazole Products Offered
10.2.5 Teva Recent Development
10.3 GeneTech Pharm
10.3.1 GeneTech Pharm Company Information
10.3.2 GeneTech Pharm Introduction and Business Overview
10.3.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GeneTech Pharm Voriconazole Products Offered
10.3.5 GeneTech Pharm Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Voriconazole Products Offered
10.4.5 Novartis Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Voriconazole Products Offered
10.5.5 Mylan Recent Development
10.6 Squibb
10.6.1 Squibb Company Information
10.6.2 Squibb Introduction and Business Overview
10.6.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Squibb Voriconazole Products Offered
10.6.5 Squibb Recent Development
10.7 Sandoz
10.7.1 Sandoz Company Information
10.7.2 Sandoz Introduction and Business Overview
10.7.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sandoz Voriconazole Products Offered
10.7.5 Sandoz Recent Development
10.8 Daiichi Sankyo
10.8.1 Daiichi Sankyo Company Information
10.8.2 Daiichi Sankyo Introduction and Business Overview
10.8.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Daiichi Sankyo Voriconazole Products Offered
10.8.5 Daiichi Sankyo Recent Development
10.9 GSK
10.9.1 GSK Company Information
10.9.2 GSK Introduction and Business Overview
10.9.3 GSK Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GSK Voriconazole Products Offered
10.9.5 GSK Recent Development
10.10 Cilag AG
10.10.1 Cilag AG Company Information
10.10.2 Cilag AG Introduction and Business Overview
10.10.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Cilag AG Voriconazole Products Offered
10.10.5 Cilag AG Recent Development
10.11 Macherey-Nagel GmbH
10.11.1 Macherey-Nagel GmbH Company Information
10.11.2 Macherey-Nagel GmbH Introduction and Business Overview
10.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Macherey-Nagel GmbH Voriconazole Products Offered
10.11.5 Macherey-Nagel GmbH Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Abbott Voriconazole Products Offered
10.12.5 Abbott Recent Development
10.13 Takeda
10.13.1 Takeda Company Information
10.13.2 Takeda Introduction and Business Overview
10.13.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Takeda Voriconazole Products Offered
10.13.5 Takeda Recent Development
10.14 Sichuan Beauty Sport Huakang Pharmaceutical
10.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
10.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Introduction and Business Overview
10.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Products Offered
10.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
10.15 Jincheng HEALTH Pharmaceutical
10.15.1 Jincheng HEALTH Pharmaceutical Company Information
10.15.2 Jincheng HEALTH Pharmaceutical Introduction and Business Overview
10.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Jincheng HEALTH Pharmaceutical Voriconazole Products Offered
10.15.5 Jincheng HEALTH Pharmaceutical Recent Development
10.16 Ebang Pharmaceutical
10.16.1 Ebang Pharmaceutical Company Information
10.16.2 Ebang Pharmaceutical Introduction and Business Overview
10.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Ebang Pharmaceutical Voriconazole Products Offered
10.16.5 Ebang Pharmaceutical Recent Development
10.17 Aditya Pharma
10.17.1 Aditya Pharma Company Information
10.17.2 Aditya Pharma Introduction and Business Overview
10.17.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Aditya Pharma Voriconazole Products Offered
10.17.5 Aditya Pharma Recent Development
10.18 Taj Pharmaceuticals
10.18.1 Taj Pharmaceuticals Company Information
10.18.2 Taj Pharmaceuticals Introduction and Business Overview
10.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Taj Pharmaceuticals Voriconazole Products Offered
10.18.5 Taj Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Voriconazole Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Voriconazole Industrial Chain Analysis
11.4 Voriconazole Market Dynamics
11.4.1 Voriconazole Industry Trends
11.4.2 Voriconazole Market Drivers
11.4.3 Voriconazole Market Challenges
11.4.4 Voriconazole Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Voriconazole Distributors
12.3 Voriconazole Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
